Monitoring of cardiac index (CI) by uncalibrated pulse contour (PC) methods has been shown to be inaccurate in critically ill patients. We tested accuracy and trending of a new pulse contour method and a modified Fick method using central venous oxygen saturation. We studied 21 critically ill and mechanically ventilated patients (age 20-86 years) monitored by PC (PulsioFlex®) and transpulmonary thermodilution (TPTD, PiCCO 2 ®) as reference. At baseline, reference and PC-derived CI (CI PC ) were recorded and CI obtained by Fick's method (FM, CI FICK ). After four hours, measurements were performed analogously for trending analysis. CI are given in l/min/m 2 as mean ± standard deviation. At baseline CI TPTD was 3.7 ± 0.7, CI PC 3.8 ± 0.7 and CI FICK 5.2 ± 1.8. After 4 hours, CI TPTD was 3.5 ± 0.6, CI PC 3.8 ± 1.2 and CI FICK 4.8 ± 1.7. Mean bias for PC at baseline was -0.1 (limits of agreement [LOA] -1.4 to 1.2) and -0.4 (LOA -2.6 to 1.9) after four hours. Percentage errors (PE) were 34% and 60% respectively. FM revealed a bias of -1.5 (LOA -4.8 to 1.8, PE 74%) at baseline and -1.5 (LOA -4.5 to 1.4, PE 68%) at four hours. With an exclusion window of 10% of mean cardiac index, trending analysis by polar plots showed an angular bias of 5° (radial LOA ± 57°) for PC and 16° (radial LOA ± 51°) for FM. Although PC values at baseline were marginally acceptable, both methods fail to yield clinically acceptable absolute values. Likewise, trending ability is not adequate for both methods to be used in critically ill patients.
Critically ill patients often receive extended haemodynamic monitoring for guidance of fluid and vasopressor therapy. Thermodilution techniques are regarded as the gold standard for cardiac output (CO) monitoring. These methods require dedicated thermistor catheters. For simplification of haemodynamic monitoring, various systems have been introduced into clinical practice designed to work only with an arterial line. These systems analyse the pulse contour waveform and take demographic variables (age, gender, height and weight) into account. Validations of these methods have led to equivocal results [1] [2] [3] [4] [5] [6] [7] [8] , and it remains unclear whether these systems' accuracy is sufficient for clinical purposes in the intensive care setting, especially in the presence of a low systemic vascular resistance. Recently, a new pulse contour monitor has been introduced into clinical practice that estimates CO from the arterial waveform and then subsequently calculates changes in CO from the waveform for trending analysis.
In the pursuit of an entirely non-invasive technique for the measurement of CO, we chose to assess a modified Fick 9 principle-derived CO based on central venous oxygen saturation to avoid the placement of a pulmonary artery catheter 10 .
In the past, attention has mainly been paid to absolute values while trending analysis is regarded to be more important nowadays.
We hypothesised that the uncalibrated pulse contour system and the modified Fick's method yield adequate trending analysis in critically ill patients and thus can be used for clinical decision-making in this patient population. The transpulmonary thermodilution (TPTD) method was used as the reference technique.
Patients and methods
After approval by our institutional review board (Ethikkommittee der Universität Witten/Herdecke, No. 20/2012, date of approval: March 19, 2012, Prof. Dr. P. W. Gaidzik), we enrolled mechanically ventilated critically ill patients. Written informed consent was obtained from patients or their next of kin. To describe patients' disease severity, the Acute Physiology And Chronic Health Evaluation II score (APACHE II) 11 and the Simplified Acute Physiology Score II (SAPS II) 12 on the day of admission and the Sequential Organ Failure Assessment Score (SOFA) 13 on the day of examination were recorded.
All patients received extended haemodynamic monitoring by the TPTD technique (PiCCO 2 ® monitor, Pulsion Medical Systems, version 1.0, Feldkirchen, Germany) prior to study inclusion whenever deemed necessary for assessment of fluid status. For TPTD measurements a 5F femoral arterial thermistor catheter (PV20L15, Pulsion Medical Systems, Feldkirchen, Germany) and a central venous catheter in the superior vena cava (Certofix® Trio, B. Braun, Melsungen, Germany) were in place. Furthermore, a radial arterial line (Leadercath 8 cm, Laboratoires Pharmaceutiques Vygon, Ecouen, France) was present before extended haemodynamic monitoring was initiated and was left in place for pulse contour measurements (Pulsioflex® monitor, version 1.0 with a ProAQT® PV8810 sensor, Pulsion Medical Systems, Feldkirchen, Germany). All patients were sedated with propofol and/or midazolam and sufentanil. Ventilation was performed in a pressure-controlled mode (BIPAP, Evita XL, Dräger, Lübeck, Germany) via an endotracheal tube (Rüsch®, Magill tube, Teleflex Medical Europe Ltd, Athlone, Ireland) with an inner diameter of 7.5 mm or 8.5 mm for female and male patients, respectively.
Oxygen uptake was calculated by the critical care monitor (Datex-Ohmeda® S/5™ with a COVX-module, GE Healthcare, Little Chalfont, United Kingdom). For blood gas sampling, a point-of-care blood gas analyser was used (GEM® Premier™ 3000, Instrumentation Laboratory, Bedford, MA, USA). For calculations of CO by the Fick principle, a data sheet was programmed (Excel 2010, Microsoft Corp., Redmond, WA, USA). To improve accuracy, the oxygen saturation of the gas samples was calculated from the oxygen partial pressure by the same algorithm as implemented in the blood gas analyser. By this step, decimals that are normally not shown by the gas analyser can be taken into account for further calculations. Fick's method normally requires mixed venous oxygen saturation, however, as has been reported before, the difference between mixed venous and central venous oxygen saturation in critical care patients is approximately 7 ± 4% 14 . Therefore mixed venous oxygen saturation was estimated from the central venous oxygen saturation by subtraction of 7%.
All systems were set up according to manufacturers' specifications. For inter-individual comparison all CO data were recorded indexed for body surface area as cardiac index (CI).
All patients underwent transthoracic echocardiography to exclude patients with any relevant aortic or mitral valve regurgitation as well as patients with a left ventricular ejection fraction below 30%.
Baseline measurements (BL) were obtained as soon as feasible after study inclusion. One central venous and one arterial blood gas analysis were performed. Triplicate readings were taken from the critical care monitor at 20 second intervals for oxygen uptake (VO 2 ). These values as well as the blood gas data were entered into the pre-programmed data sheet for calculation of CI FICK from the mean values.
Subsequently, CI of the uncalibrated pulse contour monitor (CI PC ) was calculated and recorded. Finally, reference CI TPTD was obtained by three manual central venous injections of 15 ml iced saline solution. No readings or injections were triggered by the respiratory cycle. Stroke volume variation (SVV) and pulse pressure variation (PPV) of the uncalibrated pulse contour monitor and the TPTD monitor were recorded as well.
For trending analysis, measurements were performed analogously after four hours (T4). Four hours was chosen arbitrarily, to allow for sufficient trending analysis of changes in CO. Between the timepoints, patients' therapy was conducted according to hospital protocols and was recorded with special attention to vasopressor, inotropic, and fluid therapy.
Statistical analysis
Data was tested for normality by the Kolmogorov-Smirnov test with Lilliefors' correction. All data normally distributed are given as mean ± standard deviation (P >0.05 for normal distribution). Non-normally distributed data are given as median and quartiles.
Bland-Altman's method 15 was used to analyse the relation between CI TPTD and CI PC as well as CI TPTD and CI FICK at BL and T4. Percentage errors were calculated as 100 x 1.96 x limits of agreement / mean CI as described previously 16 . For trending analysis, we performed polar plots with a 10% exclusion zone based on mean reference CI 17, 18 for CI TPTD and CI PC as well as CI TPTD and CI FICK between timepoints BL and T4. Further Bland-Altman plots were done on differences of CI for both tested methods to facilitate visualisation of the magnitude of changes studied for trending analysis. Depending on distribution, other cardiorespiratory variables were compared by Student's t-test or Wilcoxon test between BL and T4.
Microsoft Excel 2010 (Microsoft Corp., Redmond, WA, USA) was used for data management. Statistical testing was done with SPSS statistical software package (version 22, IBM Inc., Armonk, NY, USA).
A priori power calculation (two-tailed, paired design) revealed a sample size of 21 to be sufficient to detect a difference of 15% between the reference technique (CI TPTD ) and CI PC or CI FICK with an error probability for α = 0.05 and 1-β = 0.80 for an estimated average CI of 3.3 l/minute/m 2 and a standard deviation of 0.75. This estimation was derived from a previous sample from our intensive care unit 8 . A value of P less than 0.05 was considered statistically significant.
Results
Between August 24, 2012 and December 18, 2013, we studied 21 critically ill and mechanically ventilated patients (age 20 to 86 years, median SAPS II of 36 [31-46] and a median APACHE score of 27 [25] [26] [27] [28] [29] [30] [31] [32] ). Patient characteristics are summarised in Table 1 .
The main results of the haemodynamic parameters are presented in Table 2 ; Bland-Altman analysis and trending analysis are presented in Table 3 with the corresponding polar plots shown in Figures 1 and 2 . Bland-Altman plots on differences are shown in Figures 3 and 4 . Data on patient 17 is partially missing at T4 due to loss of the radial arterial line. The same patient received 1.96 µg/kg/minute of dobutamine at baseline, whereas no other patient received dobutamine during the study period. At baseline, 19 patients and at T4, 15 patients, were treated with noradrenaline. No other vasopressors were used. Although patients' mean systemic vascular resistance index (SVRI) did not change between the timepoints, patients' individual values changed resulting in a poor correlation between baseline and T4 with a R 2 = 0.41. The comparison of SVV between CI PC and CI TPTD (baseline and T4 pooled) resulted in a bias of 0 with limits of agreement (LOA) from -10 to 11 and a percentage error (PE) of 78%. For PPV bias was -1 with LOA from -10 to 8 and a PE of 75%. Mean left ventricular ejection fraction as estimated by transthoracic echocardiography was 56 ± 11%; no patient had to be excluded due to an ejection fraction below 30% or due to relevant aortic or mitral valve regurgitation. All patients were in sinus rhythm except patients 1 and 17 who were in atrial fibrillation.
Discussion
In this study, we found non-negligible differences between the baseline value of the pulse contour analysis and the reference method, which increased over the study period, questioning its clinical useability. Even more exaggerated, Fick principle-derived parameters showed an even larger deviation from TPTD measurements, yielding absolute values useless for clinical purposes. According to previously published criteria 19 , we could show poor trending ability for both methods with radial LOA far too high to be used under clinical circumstances. Fick's method showed a higher polar angle as a measurement of bias while the polar angle of the pulse contour method was within the acceptable range. Although radial LOA were nearly equal for both methods, Fick's method had a higher polar concordance rate than the pulse contour method.
The algorithm used in the tested pulse contour monitor relies on integrating the systolic portion of the pressure curve and multiplying the resulting area with the heart rate to calculate a CO. However, the area under the curve has to be calibrated with a calibration factor that mainly relies on the aortic impedance. But, the most important value contributing to the calibration factor, aortic impedance, is known to change rapidly in critically ill patients, i.e. by changes in SVRI, thus introducing a potential error into the pulse contour trending analysis 20, 21 . In this setting, a correct calibration factor taking aortic impedance into account can only be obtained with thermodilution methods. Therefore, the tested pulse contour monitor as well as other pulse contour systems must estimate the aortic impedance or calibration factor from demographic data and a dedicated waveform analysis. It has been shown for one pulse contour method, that this analysis is often troublesome and coincided with an error too high to be acceptable in intensive care medicine 3, 7 . The error margin seems to increase particularly in the presence of a low SVRI as it is often present in critically ill patients 4, 6 . In our study population, patients' individual SVRI changed between the timepoints, possibly challenging the waveform analysis by changes of the aortic impedance. At the time of enrolment in our study, most patients were already receiving vasopressors and their routine invasive blood pressure monitoring was moved up to an extended haemodynamic monitoring with thermodilution measurements. This implies that the included patients were already haemodynamically unstable and it may have posed a further challenge to the pulse wave analysis.
Other factors, like failure to correctly identify the systolic portion of the pressure curve may also play a role but are probably rather rare occurrences 22 . One of the advantages of pulse contour systems is that they may be connected to a peripheral arterial line as usually present in the intensive care setting. However, pulse contour analysis algorithms as implemented in combined thermodilution and pulse contour devices have only been validated with a femoral arterial waveform so far. It has not been shown yet whether peripheral arterial and femoral waveforms may be used interchangeably. Although not the primary objective of our study, the poor agreement between SVV and PPV from the arterial and the femoral line as expressed by a high PE suggests that the signals from the different lines may not be interchangeable, but this should be evaluated separately in the future. We suggest that the above factors may have contributed to the poor agreement concerning trending and that the still troublesome calculations to compute a calibration factor simply from demographic data and waveform analysis at baseline measurements led only to a marginal agreement at the start of data acquisition. Our data match the findings of another study evaluating trending analysis of the tested monitoring device 23 as well as preliminary data from a multicentre study 24 .
The Fick principle as used in our study was a modified approach using central venous oxygen saturation instead of mixed venous oxygen saturation as has been reported before 10 . However, we used a fixed correction of 7% between central venous and mixed venous saturation. We based this assumption on the study of Reinhart et al 14 which also reported a standard deviation of ± 4% that could not be included in our calculations. It remains unclear whether the findings of this previous study apply to our patient population. Therefore, we certainly introduced a systematic error into our results. We did not apply a shunt correction for our calculations, which may have introduced further error in our computations. Although some studies have found a good agreement between classic Fick's analysis and thermodilution measurements before [25] [26] [27] , lack of agreement has been reported as well with LOA too high to be considered acceptable 28 . Furthermore, the module we used for measuring oxygen consumption has not been validated in this setting so far. Considering the limitations of the modified method as used in this study, it is unsurprising that agreement with TPTD was poor. Interestingly, trending analysis by the Fick principle was not inferior to the pulse contour method, even showing lower radial LOA. The radial angle of 16° indicates a systematic bias that may have been introduced by our calculations as indicated above but should not have influenced the trending ability.
Although pulse contour analysis is not showing acceptable agreement with validated systems, there are data that suggest a benefit for pulse contour analysis-based treatment algorithms in the operating suite 29 .
Our study suffers from several potential limitations. Unfortunately, we did not access raw data on the TPTD device so we cannot comment on changes in the calibration factor which would have been useful to estimate changes in aortic impedance. Data was recorded at only two timepoints with no defined intervention in between. Therefore, only sparse data was available for trending analysis, especially after applying the exclusion window to the analysis. As outlined above, our study population was heterogeneous in severity of illness and age. The small sample size of 21 patients limits the power of this study and it is uncertain whether these results are applicable to a larger population.
Conclusion
The estimation of CI from waveform analysis by the pulse contour monitor resulted in values that showed marginal agreement with the reference method. Other CI values were beyond the range that is regarded as clinically acceptable. Trending ability of the pulse contour analysis and the modified Fick principle was poor. Until further studies define the value of pulse contour systems in critically ill patients, we recommend using validated systems, i.e. thermodilution methods, for extended haemodynamic monitoring in the intensive care setting.
